EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 152 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.87 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $967,000 | -15.0% | 19,159 | -32.2% | 0.00% | 0.0% |
| Q4 2018 | $1,138,000 | -71.0% | 28,239 | -50.1% | 0.00% | 0.0% |
| Q3 2018 | $3,928,000 | +135.6% | 56,644 | +157.1% | 0.00% | 0.0% |
| Q2 2018 | $1,667,000 | +55.9% | 22,036 | +8.6% | 0.00% | 0.0% |
| Q1 2018 | $1,069,000 | -1.4% | 20,296 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $1,084,000 | -20.6% | 20,296 | -11.4% | 0.00% | 0.0% |
| Q3 2017 | $1,366,000 | -23.8% | 22,910 | +0.8% | 0.00% | 0.0% |
| Q2 2017 | $1,793,000 | -10.4% | 22,734 | -5.7% | 0.00% | 0.0% |
| Q1 2017 | $2,000,000 | -1.6% | 24,110 | -5.9% | 0.00% | -50.0% |
| Q4 2016 | $2,033,000 | +11.0% | 25,626 | -2.1% | 0.00% | +100.0% |
| Q3 2016 | $1,832,000 | +79.4% | 26,175 | -0.6% | 0.00% | 0.0% |
| Q2 2016 | $1,021,000 | -4.7% | 26,327 | -0.4% | 0.00% | 0.0% |
| Q1 2016 | $1,071,000 | -59.6% | 26,434 | -11.7% | 0.00% | -50.0% |
| Q4 2015 | $2,654,000 | +16.7% | 29,927 | -2.6% | 0.00% | 0.0% |
| Q3 2015 | $2,275,000 | -11.9% | 30,728 | -3.8% | 0.00% | 0.0% |
| Q2 2015 | $2,582,000 | – | 31,932 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |